8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors
- 1 April 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (7) , 1431-1435
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2013
- Clinical use of sildenafil in pulmonary artery hypertensionExpert Review of Respiratory Medicine, 2010
- Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533)Bioorganic & Medicinal Chemistry Letters, 2010
- Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety databaseInternational Journal Of Clinical Practice, 2009
- Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5International Journal Of Impotence Research, 2004
- The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione AnaloguesJournal of Medicinal Chemistry, 2003
- The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione AnaloguesJournal of Medicinal Chemistry, 2003
- Erectile DysfunctionNew England Journal of Medicine, 2000
- 4-(3-Chloro-4-methoxybenzyl)aminophthalazines: Synthesis and Inhibitory Activity toward Phosphodiesterase 5Journal of Medicinal Chemistry, 2000
- Sildenafil (Viagra) and OphthalmologySurvey of Ophthalmology, 1999